Hacker News Reader

Not against researching other candidates as well. But mRNA has a proven track record and extending it to other diseases is a promising track.

You can fund research in those other areas without cutting mRNA. Sure it'll cost more $ but there's plenty of that - ffs we're spending $150 billion _more_ on "border security".

View on HN

Yes and those are being funded well. Look at HIV and cancer mRNA breakthroughs. Those aren’t being cut.

This is specifically about COVID-19 and flu. Which after 5 years we have better science supporting how to combat them long term.

I think a lot of people miss that nuance because of who the message is coming from.

> Which after 5 years we have better science supporting how to combat them long term.

bird flu, not sure; but as for covid no other method has anywhere near the large scale data supporting it since mRNA was the only one deployed to millions. Do I don't really agree that we have "better science" that shows other methods are more effective.

Have you heard of Novavax or any of the intranasal vaccines in late trials?

Yes, but 1) phase3 trials are still underway, and 2) it's good to have alternatives but it doesn't mean their approach is better than mRNA

Reply on news.ycombinator.com